Minimal change disease and focal segmental glomerulosclerosis

Fundamentals of Renal Pathology

Volumn , Issue , 2007, Pages 40-52

  Fogo, Agnes B ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84869098047     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-31127-2_4     Document Type: Chapter

References (44)

1. Southwest Pediatric Nephrology Study Group. A report: focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. Kidney Int 27:442-449, 1985.
2. Haas M, Spargo B, Coventry S. Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study. Am J Kidney Dis 26:740-750, 1995.
3. Braden GL, Mulhern JG, O'Shea MH, Nash SV, Ucci AA Jr, Germain MJ. Changing incidence of glomerular diseases in adults. Am J Kidney Dis 35:878-883, 2000.
4. Andreoli SP. Racial and ethnic differences in the incidence and progression of focal segmental glomerulosclerosis in children. Adv Ren Replace Ther 11:105-109, 2004.
5. Rich AR. A hitherto undescribed vulnerability of the juxta-medullary glomeruli in lipoid nephrosis. Bull Johns Hopkins Hosp 100:173-186, 1957.
6. D'Agati V. The many masks of focal segmental glomerulosclerosis. Kidney Int 46:1223-1241, 1994.
7. Fogo A, Glick AD, Horn SL, Horn RG. Is focal segmental glomerulosclerosis really focal? Distribution of lesions in adults and children. Kidney Int 47:1690-1696, 1995.
8. Corwin HL, Schwartz MM, Lewis EJ. The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol 8:85-89, 1988.
9. Smith SM, Hoy WE, Cobb L. Low incidence of glomerulosclerosis in normal kidneys. Arch Pathol Lab Med 113:1253-1256, 1989.
10. D'Agati V. P a t hologic classification of focal segmental glomerulosclerosis. Semin Nephrol 23:117-134, 2003.
11. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis 43:368-382, 2004.
12. Detwiler RK, Falk RF, Hogan SL, Jennette JC. Collapsing glomerulopathy: a clinically and pathologically distinct Variant of focal segmental glomerulosclerosis. Kidney Int 45:1416-1424, 1994.
13. Valeri A, Barisoni L, Appel GB, Seigle R, D'Agati V. Idiopathiccol lapsing focal segmental glomerulosclerosis: a clinicopathologic study. Kidney Int 50:1734-1746, 1996.
14. Howie AJ, Brewer DB. Further studies on the glomerular tip lesion: early and late stages and life table analysis. J Pathol 147:245-255, 1985.
15. Stokes MB, Markowitz GS, Lin J, Valeri AM, D'Agati VD. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Kidney Int 65:1690-1702, 2004.
16. Haas M, Yousefzadeh N. Glomerular tip lesion in minimal change nephropathy: a study of autopsies before 1950. Am J Kidney Dis 39:1168-1175, 2002.
17. Chun MJ, Korbet SM, Schwartz MM, Lewis EJ. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 15:2169-2177, 2004.
18. Cohen AH, Nast CC. HIV-associated nephropathy: a unique combined glomerular, tubular, and interstitial lesion. Mod Pathol 1:87-97, 1988.
19. Fogo A, Hawkins EP, Berry PL, et al. Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 38:115-123, 1990.
20. Fogo A, Ichikawa I. Focal segmental glomerulosclerosis-a view and review. Pediatr Nephrol 10:374-391, 1996.
21. Tejani A, Stablein DH. Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 2(12 suppl):S258-263, 1992.
22. Savin VJ, Sharma R, Sharma M, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878-883, 1996.
23. Barisoni L, Kriz W, Mundel P, D'Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and H I V-a ssociated nephropathy. J Am Soc Nephrol 10:51-56, 1999.
24. Ruotsalainen V, Ljungberg P, Wartiovaara J, et al. Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci USA 96:7962-7967, 1999.
25. Shih NY, Li J, Karpitskii V, et al. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 286(5438):312-315, 1999.
26. Kim JM, Wu H, Green G, et al. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300(5623):1298-1300, 2003.
27. Gubler MC. Podocyte differentiation and hereditary proteinuria/nephrotic syndromes. J Am Soc Nephrol 14(suppl 1):S22-26, 2003.
28. Pollak MR. The genetic basis of FSGS and steroid-resistant nephrosis. Semin Nephrol 23:141-146, 2003.
29. Kaplan JM, Kim SH, North KN, et al. Mutations in ACTN4, encoding alphaactinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 24:251-256, 2000.
30. Michaud JL, Lemieux LI, Dube M, Vanderhyden BC, Robertson SJ, Kennedy CR. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4. J Am Soc Nephrol 14:1200-1211, 2003.
31. Boute N, Gribouval O, Roselli S, et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24:349-354, 2000.
32. Bertelli R, Ginevri F, Caridi G, et al. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 41:1314-1321, 2003.
33. Koziell A, Grech V, Hussain S, et al. Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration. Hum Mol Genet 11:379-388, 2002.
34. Karle SM, Uetz B, Ronner V, Glaeser L, Hildebrandt F, Fuchshuber A. Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13:388-393, 2002.
35. Ruf RG, Lichtenberger A, Karle SM, et al. Arbeitsgemeinschaft Fur Padiatrische Nephrologie Study Group. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 15:722-732, 2004.
36. Regele HM, Fillipovic E, Langer B, et al. Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis. J Am Soc Nephrol 11:403-412, 2000.
37. Auber F, Lortat-Jacob S, Sarnacki S, et al. Surgical management and genotype/phenotype correlations in WT1 gene-related diseases (Drash, Frasier syndromes). J Pediatr Surg 38:124-129, 2003.
38. Ito S, Hataya H, Ikeda M, et al. Alport syndrome-like basement membrane changes in Frasier syndrome: an electron microscopy study. Am J Kidney Dis 41:1110-1115, 2003.
39. Denamur E, Bocquet N, Baudouin V, et al. WT1 splice-site mutations are rarely associated with primary steroid-resistant focal and segmental glomerulosclerosis. Kidney Int 57:1868-1872, 2000.
40. Moudgil A, Nast CC, Bagga A, et al. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 59:2126-2133, 2001.
41. Markowitz GS, Appel GB, Fine PL, et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 12:1164-1172, 2001.
42. Jennette JC, Hipp CG. C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 6:103-110, 1985.
43. Markowitz GS, Schwimmer JA, Stokes MB, et al. C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int 64:1232-1240, 2003.
44. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59:1498-1509, 2001.